Skip to main content
ALHC
NASDAQ Finance

Alignment Healthcare Reports Strong Q1 Results, Swings to Profit, and Raises Full-Year Guidance

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
7
Price
$20.75
Mkt Cap
$4.605B
52W Low
$11.625
52W High
$23.87
Market data snapshot near publication time

summarizeSummary

Alignment Healthcare announced robust first-quarter 2026 financial results, including significant revenue and membership growth, a return to net profitability, and an upward revision of its full-year financial outlook.


check_boxKey Events

  • Strong Q1 2026 Financial Performance

    Total revenue grew 33.3% year-over-year to $1,235.2 million, with Medicare Advantage membership increasing 30.9% to approximately 284,800 members. Adjusted gross profit rose 36.1% to $145.9 million, and Adjusted EBITDA surged 87.6% to $37.9 million.

  • Return to Net Profitability

    The company reported a net income of $11.4 million for Q1 2026, a significant improvement from a net loss of $9.4 million in the prior-year period. Income from operations also turned positive at $15.5 million.

  • Raised Full-Year Guidance

    Alignment Healthcare increased the midpoint of its guidance for all key metrics, including membership, total revenue (now $5,160M - $5,205M), adjusted gross profit, and adjusted EBITDA (now $138M - $163M) for fiscal year 2026.


auto_awesomeAnalysis

Alignment Healthcare's 8-K filing confirms robust first-quarter 2026 financial results, demonstrating significant year-over-year growth in revenue and membership. Crucially, the company swung from a net loss in the prior year to a net income of $11.4 million, indicating improved operational efficiency and profitability. The upward revision of full-year guidance for all key financial metrics signals management's confidence in continued strong performance, providing a positive outlook for investors. While some revenue figures were previously reported by news outlets, this filing provides the complete, official financial statements and detailed guidance, offering a comprehensive view of the company's strong trajectory.

At the time of this filing, ALHC was trading at $20.75 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $11.63 to $23.87. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ALHC - Latest Insights

ALHC
May 12, 2026, 4:34 PM EDT
Filing Type: DEFA14A
Importance Score:
7
ALHC
May 12, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
ALHC
May 12, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
ALHC
Apr 30, 2026, 4:01 PM EDT
Source: Reuters
Importance Score:
8
ALHC
Apr 30, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
ALHC
Apr 24, 2026, 10:52 AM EDT
Filing Type: DEF 14A
Importance Score:
7
ALHC
Mar 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
ALHC
Mar 03, 2026, 3:13 PM EST
Filing Type: 424B7
Importance Score:
7
ALHC
Mar 02, 2026, 9:05 PM EST
Source: GlobeNewswire
Importance Score:
7
ALHC
Mar 02, 2026, 4:49 PM EST
Source: Reuters
Importance Score:
7